Romina G. Diaz

La Plata, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A Preclinical Investigation of Estrogenic Bone Protection in a Hypertensive Rat Model Under Gender-Affirming Hormone Therapy.

A Preclinical Investigation of Estrogenic Bone Protection in a Hypertensive Rat Model Under Gender-Affirming Hormone Therapy.

Journal: Biology

Published: May 02, 2025

TRPV4 channels mediate exacerbated response to mechanical cues in spontaneously hypertensive rats.

TRPV4 channels mediate exacerbated response to mechanical cues in spontaneously hypertensive rats.

Journal: Journal of hypertension

Published: February 21, 2025

Cardiovascular risk of gender-affirming estrogen therapy in a transgender rat model.

Cardiovascular risk of gender-affirming estrogen therapy in a transgender rat model.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: February 05, 2025

Isolated Morning Hypertension is a Predictor of Cardiovascular Events in Treated and Well Controlled Hypertensive Patients.

Isolated Morning Hypertension is a Predictor of Cardiovascular Events in Treated and Well Controlled Hypertensive Patients.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Published: January 10, 2025

Amiodarone oral subacute treatment prevents cardiac dysfunction of ischemia/reperfusion in rats: Mechanisms and influence of hypothyroidism.

Amiodarone oral subacute treatment prevents cardiac dysfunction of ischemia/reperfusion in rats: Mechanisms and influence of hypothyroidism.

Journal: European journal of pharmacology

Published: December 20, 2024

Hydrocortisone cardioprotection in ischaemia/reperfusion injury involves antioxidant mechanisms.

Hydrocortisone cardioprotection in ischaemia/reperfusion injury involves antioxidant mechanisms.

Journal: European journal of clinical investigation

Published: October 27, 2023

Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved.

Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: May 03, 2023

Cardioprotective effects of N-methylacetazolamide mediated by inhibition of L-type Ca2+ channel current.

Cardioprotective effects of N-methylacetazolamide mediated by inhibition of L-type Ca2+ channel current.

Journal: Biochimica et biophysica acta. General subjects

Published: August 31, 2021

Thioredoxin 1 (TRX1) Overexpression Cancels the Slow Force Response (SFR) Development.

Thioredoxin 1 (TRX1) Overexpression Cancels the Slow Force Response (SFR) Development.

Journal: Frontiers in cardiovascular medicine

Published: October 28, 2020

Myocardial Impact of NHE1 Regulation by Sildenafil.

Myocardial Impact of NHE1 Regulation by Sildenafil.

Journal: Frontiers in cardiovascular medicine

Published: October 14, 2020

PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy.

PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy.

Journal: European journal of pharmacology

Published: April 29, 2020

Silencing of epidermal growth factor receptor reduces Na+/H+ exchanger 1 activity and hypertensive cardiac hypertrophy.

Silencing of epidermal growth factor receptor reduces Na+/H+ exchanger 1 activity and hypertensive cardiac hypertrophy.

Journal: Biochemical pharmacology

Published: June 28, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026